List your company

RoI-level Breast Cancer Tumor Subtyping on BACH (test)

88.35AUROCGrapHist
45.065256.302667.5478.7774Feb 24, 2026

Evaluation results

MethodLinks
GrapHistAggregation=add-ABMIL2026.0288.35—
GrapHistAggregation=ABMIL2026.0288.01—
GrapHistAggregation=conj-ABMIL2026.0286.47—
DINOv2Aggregation=add-ABMIL2026.0284.38—
DINOv2Aggregation=ABMIL2026.0280.87—
MAEAggregation=add-ABMIL2026.0280.76—
MAEAggregation=conj-ABMIL2026.0278.11—
DINOv2Aggregation=conj-ABMIL2026.0276.56—
MAEAggregation=ABMIL2026.0275.11—
ACM-bioAggregation=add-ABMIL2026.0266.44—
ACM-UNIAggregation=add-ABMIL2026.0264.9—
ACM-UNIAggregation=ABMIL2026.0255.97—
ACM-UNIAggregation=conj-ABMIL2026.0252.69—
ACM-bioAggregation=ABMIL2026.0250.21—
ACM-bioAggregation=conj-ABMIL2026.0246.73—
ACM-bioModel Category=Supervised graph models, MIL aggregation=best variant2026.02—38.37
ACM-UNIModel Category=Supervised graph models, MIL aggregation=best variant2026.02—29.03
DINOv2Model Category=Self-supervised vision models, MIL aggregation=best variant2026.02—59.25
GrapHistModel Category=Ours, MIL aggregation=best variant2026.02—69.16
MAEModel Category=Self-supervised vision models, MIL aggregation=best variant2026.02—57.94